Article
Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based IdyllaTM System.
Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000
Boustany Youssra, Laraqui Abdelilah, El Zaitouni Sara, Ghaouti Merieme, Benzekri Asmae, Kettani Fouad, Oukabli Mohammed, Ennibi Khalid, Belkadi Bouchra, Sekhsokh Yassine
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation status is of a major clinical significance in non-small cell lung cancer (NSCLC) management, as it guides therapeutic decision making to target patients for a better response to therapy. This implicates the introduction of EGFR mutation analysis as the standard of care for Moroccan NSCLC patients, which in itself entails the implementation of targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
